Capital Markets this Morning:

The futures are up a little this morning, here is what is in focus globally for stocks:

• USD hits 34-year high against yen, prompting Japan's intervention warning. Nikkei jumps nearly 1%.

• Chinese stocks near one-month lows despite industrial profit rise; foreign investors pull out nearly $1 billion.

• Hawkish Federal Reserve outlook and strong U.S. economic data boost dollar; Swiss franc falls to weakest since Nov 3.

• European central banks' easing signals weaken local currencies; ECB sees inflation at 2% target by mid-2025.

• U.S. stocks aim for rebound; attention on Trump Media's Nasdaq debut and Biden's rising approval ratings.

Capital Markets this Morning:

Organigram (NASDAQ: OGI, TSX: OGI) invests $2M in Open Book Extracts through a convertible note. This move marks its first Jupiter pool investment, expanding its U.S. market footprint and hemp product potential. —— And that is not all: Organigram also announces a C$25 million public offering of units. The offering aims to fund growth and for general corporate purposes, indicating expansion and investment plans.

TDR Takeaway: Organigram is currently expanding in the USA, presenting an opportunity, albeit with a cost of approximately 17% dilution to shareholders. It is important to closely monitor whether the benefits of this expansion outweigh the dilution faced by shareholders. For more information, visit the TDR website.

Capital Markets this Morning:

Who is positioned too benefit the most from Germany’s Legalization?

TDR Takeaway: Germany's opening of its cannabis market has put firms like Tilray and Aurora in the spotlight as frontrunners, marking a significant shift in the industry. This move towards legalization also signals a promising period of growth for companies such as Canopy Growth and Curaleaf, highlighting their potential in Germany. Furthermore, entities like Village Farms are keenly observing Germany's cannabis sector, eyeing opportunities for expansion and aiming to carve out their own space in this growing market. Read all about it on the TDR Website!

Cannabis Politics this Morning:

President Biden is targeting young voters with a focus on marijuana policy reform, aiming to engage this key demographic by reclassifying cannabis under federal law and taking incremental steps towards broader policy changes.

TDR Takeaway: Biden's administration is actively reshaping marijuana policies, including pushing for the reclassification of cannabis and opposing incarceration for its use, targeting the crucial young voter demographic. This shift towards more progressive drug policies, despite challenges and calls for more drastic measures like full legalization, marks a departure from Biden's historically stringent stance on drug laws. It's a strategic move aimed at aligning with young voters' preferences, demonstrating the administration's commitment to not just drug policy reform, but also to broader issues such as college affordability and climate change that matter to this key electoral group. Read all about it on the TDR Website!

Psychedelics this Morning:

High-profile executives and professionals are exploring psychedelics to unlock business opportunities and foster team bonding.

TDR Takeaway: In professional circles, notably among tech leaders like Elon Musk, psychedelics such as LSD, psilocybin, and ketamine are gaining traction as means to enhance productivity, creativity, and teamwork. Despite anecdotal evidence of their benefits, scientific research on microdosing's effectiveness remains mixed, highlighting both potential advantages and risks. The trend raises concerns about health, legal issues, and workplace pressure to use these substances. As psychedelics become more embedded in corporate innovation and leadership development, with executives participating in transformative retreats, it's crucial to approach their use cautiously, balancing potential benefits against risks while prioritizing safety and ethics. Read all about it on the TDR Website!

Crypto this Morning:

Spot Bitcoin ETFs see a recovery with $418 million inflows, marking the largest since March 13. This resurgence is pivotal for the market, especially after a week of outflows totalling $887.6 million.

The TDR Takeaway! The resurgence in spot Bitcoin ETFs, marked by an impressive $418 million in inflows, has played a pivotal role in the recent recovery of the Bitcoin market, pushing its price back over the $70,000 threshold this morning. This significant influx, particularly led by ETFs such as Fidelity's Wise Origin Bitcoin and BlackRock’s iShares Bitcoin Trust, underscores a strong correlation between ETF buying activities and the upward trajectory of Bitcoin prices. The synchronized growth highlights not only the impactful role of institutional investments in the crypto market but also signals a growing investor confidence in Bitcoin as a investment option for diversification. Read all about it on the TDR Website!

AI this Morning:

Can AI Replace Search Engines? Despite AI progress, traditional engines like Google lead in speed and accuracy. AI struggles with navigation but shows potential in in-depth exploration.

The TDR Takeaway! AI advancements haven't dethroned traditional search engines like Google due to their speed and accuracy in handling navigation and information queries. AI engines struggle with direct navigational tasks but show promise in exploration and synthesis, suggesting a potential niche in providing in-depth insights despite current limitations. Read all about it on the TDR Website!

Trade to Black Today at 4pm EST Live!

In today's episode of the Trade To Black podcast, we discuss the potential impact of recreational cannabis in Florida as the Supreme Court edges closer to a crucial decision. With the initiative potentially being added to the November ballot, we explore the market ramifications. Despite anticipation around the rescheduling of cannabis, stocks remain strong, signaling an optimistic market. Additionally, we'll dissect the recent announcement from Atai Life Sciences, detailing the promising initial results of Beckley Psytech’s Phase 2a open-label study of BPL-003 (Intranasal 5-MeO-DMT) for treatment-resistant depression.

Trade to Black Yesterday with Ryan Crandall of MariMed

On yesterday’s episode of TDR's "Trade To Black" podcast, we interview Ryan Crandall, Chief Revenue Officer of MariMed. We will give you a behind-the-scenes look at Marimed's Strategic Development. We dive into the triumphant return of Betty's Eddies, a popular edible, and discuss the thriving wholesale market in Illinois. We also explore the strategic growth plans that will pave the way for Marimed to reach the next level successfully. You'll discover more about the unique products, vertical integration, and the transformative impact on consumers.